| R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions. Lewis X oligosaccharides targeting to DC-SIGN enhanced antigen-specific immune response.
Authors: Wang J, Zhang Y, Wei J, Zhang X, Zhang B, Zhu Z, Zou W, Wang Y, Mou Z, Ni B, Wu Y
Immunology, 2007;121(2):174-82.
Species: Human
Sample Type: Whole Cells
Ectopic expression of the proto-oncogene Mer in pediatric T-cell acute lymphoblastic leukemia.
Authors: Graham DK, Salzberg DB, Kurtzberg J, Sather S, Matsushima GK, Keating AK, Liang X, Lovell MA, Williams SA, Dawson TL, Schell MJ, Anwar AA, Snodgrass HR, Earp HS
Clin. Cancer Res., 2006;12(9):2662-9.
Species: Human
Sample Type: Whole Cells
Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
Authors: Brando C, Mukhopadhyay S, Kovacs E, Medina R, Patel P, Catina TL, Campbell KS, Santoli D
J. Leukoc. Biol., 2005;78(2):359-71.
Species: Human
Sample Type: Whole Cells
Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay.
Authors: Ogilvie RL, Abelson M, Hau HH, Vlasova I, Blackshear PJ, Bohjanen PR
J. Immunol., 2005;174(2):953-61.
Species: Human
Sample Type: Whole Cells
In vitro engagement of CD3 and CD28 corrects T cell defects in chronic lymphocytic leukemia.
Authors: Bonyhadi M, Frohlich M, Rasmussen A, Ferrand C, Grosmaire L, Robinet E, Leis J, Maziarz RT, Tiberghien P, Berenson RJ
J. Immunol., 2005;174(4):2366-75.
Species: Human
Sample Type: Whole Cells
|
